investor presentation november
TRANSCRIPT
Achmea Investor Presentation
November 2013
“The leading Dutch insurance company with strong brands,
multi-channel distribution strategy, well-diversified product range
and conservative investment profile”
CONTENTS
Introduction
Strategic agenda
Achmea overview
Key investment considerations
Recent results
Wrap-up
Appendices
2
ACHMEA OVERVIEW - strong brands, diversified products, focus on insurance
• Largest Dutch insurer
• A strong and solid insurance group with mutual roots
• Market leader in Dutch insurance: Property &
Casualty, Income Protection, Health, Pension & Life
insurance
• Distribution mainly through direct & banking
channels and well positioned for future market
developments
• Strong market position with ‘power brands’ Interpolis,
Centraal Beheer Achmea and Zilveren Kruis Achmea
• A+ IFSR, A- senior unsecured debt (S&P)
Earned premiums by segment in H1 2013 31/12/2012 - Total: € 22.4 billion
Introduction | Achmea Overview
3
13%
16%
5%66%
Pension & Life
Non-life
International
Health
29%
29%
22%
6%
13%
1%Turkey
Greece
Slovakia
Ireland
Russia
Other
The strength of our identity and our story
We continue to build on our foundation of unity. Insurance stands
for solidarity in society. We want our customers to continue to
experience that we are a cooperative insurer.
COOPERATIVE IDENTITY
4 4
Introduction | Achmea Overview
5
The history of Achmea*
begins in Achlum, the
Netherlands
The first Dutch direct
writer FBTO is founded
Achmea founded out of
AVCB and Zilveren Kruis
Achmea merges with
Interpolis; Rabobank
becomes second largest
shareholder
A group of Dutch mutual
insurers form the
Coöperatieve Vereniging
Centraal Beheer
Achmea acquires
Interamerican Greece
Achmea acquires 80%
of Eureko Sigorta;
Achmea and Agis merge
Achmea creates
InShared
ACHMEA HISTORY
Achmea acquires Oranta
in Russia
Achmea merges with
DFZ and acquires
Independer.nl
Centraal Beheer and
Avéro Insurance merge
to AVCB
1811 2008
2007
2005
2001
1995
1992
1956
2010
2011
1909
2010-2013: Divestment
operating companies
Belgium, France,
Poland, Romania
Bulgaria
Expansion
Focus:
optimization
and innovation
* Eureko was the former name of the parent company of Achmea and its European subsidiaries.
Introduction | Achmea Overview
Eureko acquired first
international activities
1999
OWNERSHIP STRUCTURE - stability through two major cooperative shareholders
Ordinary
shares
94.5%
Achmea
subholding
5.5%
Rabobank
Netherlands
29.2%
Preference
shareholders
100%
Other
5.5%
Achmea
Association
65.3%
Introduction | Achmea Overview
• The mission of Achmea Association is to support the continuity of Achmea and to look after the collective interests of
customers
6
ACHMEA’S STRONG ALLIANCE WITH RABOBANK
• Commercial alliance through the banking
channel. Approximately 98% of insurance
products sold via the Rabobank channel are
Achmea insurance products
• Exclusive distribution of Interpolis products
through Rabobank branches
• Greenfield operation in Australia in
cooperation with Rabobank started in 2013,
with a possible extension to other growth
markets. Focus is on non-life, mainly
agricultural sector such as live stock,
machinery, crop insurance etc.
• Rabobank has a nomination vote on the
supervisory board of Achmea. Furthermore
Rabobank and Achmea share two common
supervisory board members
• Rabobank has historically supported
Achmea with capital, as and when
necessary
Commercial
Governance
Capital
Introduction | Achmea Overview
25%
22%
Wholesale Private
Rabobank customers with
Interpolis products
30/06/2013
Source: Achmea data June 2013
7
CLEAR LONG-TERM STRATEGIC CHOICES FOR DUTCH PORTFOLIO
Banking distribution
Direct distribution
Broker distribution
Property & Casualty
Health
Income Protection
Pension - standardised
Life - standardised
Banking products
Pension – not standardised
Life – not standardised
Core proposition: strengthen
Develop to core proposition
Separate and manage
internally or externally
Complementary to insurance products
Increase scale to core proposition
Product Group
Brand
Channel
Introduction | Strategic agenda
8
• Our international strategy is based on these strategic choices
CONTENTS
Introduction
Well positioned with strong brands
Dominant player in major insurance market
Robust capital and solvency position
Key investment considerations
Recent results
Wrap-up
Conservative investment profile
Appendices
9
0,75
(1,25)
THE NETHERLANDS – major insurance market within Eurozone
Netherlands CDS remains low
European Non-life market (incl. health)
0
10
20
30
40
50
60
70
80
90
100
DE FR UK NL IT ES CH
In €
bill
ion
(6)
(4)
(2)
0
2
4
6
’02 ’03 ’04 ’05 ’06 ’07 ’08 ’09 ’10 ’11 ’12 '13E 14E
Growth outlook (% change yoy)
Source: Bloomberg, Life and Non-life market: Insurance Europe, Pension market: Towers Watson Global Pension Assets Study 2013
*Pension market Netherlands per 31-12-2013: DNB
Key investment considerations | Dominant player in major insurance market
31/12/2011
10
31/12/2011
European Pension and Life assets
LEADING POSITIONS IN OUR CORE MARKETS
Key investment considerations | Dominant player in major insurance market
*Pensions based on % recurring premiums, all other segments based on % GWP
Source: DNB October 2013 (Property & Casualty, Income Protection, Individual life), Achmea (Pensions, Health)
Property &
Casualty
Individual Life
Pensions
Income
Protection
Health #1
#1
#2
#4
#2
Delta
Lloyd
Delta
Lloyd
Delta
Lloyd
a.s.r.
a.s.r.
a.s.r.
ING
ING
Atradius ING Other
Other
Other
Other
Other VGZ CZ Menzis
Aegon SNS
Reaal
SNS
Reaal
Market share per 31-12-2012*
11
a.s.r. ING
SNS
Reaal
De
Goudse Delta
Lloyd Aegon
Aegon
CONTENTS
Introduction
Well positioned with strong brands
Dominant player in major insurance market
Robust capital and solvency position
Key investment considerations
Recent results
Wrap-up
Conservative investment profile
Appendices
12 12
WELL DIVERSIFIED DISTRIBUTION NETWORK OF ACHMEA
• Well diversified distribution
network consisting of banking,
direct and intermediary channel
• Share of controlled distribution
(direct and banking channel)
among product lines is highest
in health insurance (~97%)
• Banking distribution of
insurance products uses
Rabobank channel in the
Netherlands
Non-life
Health Pension & Life
Key investment considerations | Well positioned with strong brands
13
31/12/2011
31/12/2011 31/12/2011
14
Retail customers
Wholesale customers
AROUND HALF OF ALL DUTCH PEOPLE ARE ACHMEA CUSTOMERS
Key investment considerations | Well positioned with strong brands
14
60
70
80
90
100
110
120
130
40 60 80 100 120 140
60
70
80
90
100
110
120
130
40 60 80 100 120 140
60
70
80
90
100
110
120
130
40 60 80 100 120 140
Property & Casualty Health Individual life
BRAND POWER
Source: Achmea brandpower research, Property & Casualty (July 2013), Health (Dec 2012), Individual Life (Dec 2012)
Brand strength
Bra
nd
lo
ya
lty
Achmea Competitor
Key investment considerations | Well positioned with strong brands
15
HIGH CUSTOMER SATISFACTION
Ø 7,7
Nationale Nederlanden 7,3
Avéro Achmea 7,5
SNS Reaal 7,6
Delta Lloyd 7,6
Generali 7,7
ASR 7,7
FBTO 7,7
Interpolis 7,7
ABN Amro 7,8
Aegon 7,8
Centraal Beheer Achmea 7,8
P&C Retail
Ø 7,3
7,1
7,2
Avéro Achmea
7,3
7,3
7,3
7,3
De Goudse
7,4
ABN Amro
7,5
Generali
ASR
Aegon
Interpolis
Centraal Beheer Achmea
P&C Wholesale Income Protection
Ø 7,1
De Amersfoortse
7,0
Avéro Achmea
7,1
7,1
Interpolis
7,2
7,2
7,2 Centraal Beheer Achmea
Generali
De Goudse
Key investment considerations | Well positioned with strong brands
Source: Verbond van Verzekeraars, Customer Satisfaction Research 2012
Pensions
Ø 6,5
6,0
6,4
6,4 ASR
6,4
6,5
Aegon
7,0
Generali
7,2
Avéro Achmea
Delta Lloyd
Interpolis
Centraal Beheer Achmea
Individual Life
Ø 7,1
6,2
6,4
6,5
Nationale Nederlanden 6,5
6,9
6,9
7,1
SNS Reaal
7,3
7,3
7,3
Allianz
7,4
Aegon
7,4
Avéro Achmea
ABN Amro
Generali
FBTO
Delta Lloyd
Cardiff
Interpolis
Centraal Beheer Achmea
Health
Ø 7,7
7,4
7,5
7,6
Agis
Avéro Achmea 7,6
7,6
7,7
7,8
De Amersfoortse
7,9
VGZ
8,1
Zilveren Kruis Achmea
FBTO
Univé
OZF Achmea
Pro Life
Interpolis
7,5
16
CONTENTS
Introduction
Well positioned with strong brands
Dominant player in major insurance market
Robust capital and solvency position
Key investment considerations
Recent results
Wrap-up
Conservative investment profile
Appendices
17 17
HIGH QUALITY OF CAPITAL AND LOW LEVERAGE
75%
13%
12%
Core capital
Hybrid capital
Debt
22% 23% 22% 21% 21% 22%
27%
Maximum level
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
Dec 11 Mar 12 Jun 12 Sep 12 dec-12 mrt-13 jun-13
Capital structure
Debt leverage Composition of equity
Capital allocation
30/06/2013 - Total: € 11.1 billion
30/06/2013 - Total: € 9.8 billion
30/06/2013 - Total: € 11.1 billion
Key investment considerations | Robust capital and solvency position
18
SOLID SOLVENCY I POSITION
Solvency I
Key investment considerations | Robust capital and solvency position
19
STRONG SOLVENCY POSITION COMPARED TO EUROPEAN PEERS
257%
234%
220%
218%
204%
184%
180%
177%
172%
139%
116%
0% 50% 100% 150% 200% 250% 300%
ING EurAsia
Achmea excl. Health
Aegon (NL)
Axa
Achmea
Delta Lloyd
Aviva
Allianz
SNS Reaal
Generali
CNP Assurances
Solvency I (IGD) at 30/06/2013
Key investment considerations | Robust capital and solvency position
20
Available capital
8.2
Required capital
4.0
Surplus
4.2
STRONG SOLVENCY POSITION UNDER ALL REGIMES
Solvency I (IGD)
204%
SCR level
Available Capital
7.7 2.8
Free surplus
3.5
MCR level
4.2
Solvency II* (Partial Internal Model)
183%
Key investment considerations | Robust capital and solvency position
*excl. D&A: banks, IORP’s, Non-EEA
• Solvency II framework is still evolving; parameter changes (e.g. interest rate assumptions) make yearly
comparison of full year run outcomes difficult
• Assumptions in our 2012 model are set conservative. Most recent proposals on the treatment of long-term
guarantees will result in a significant increase in solvency levels for the life entities compared to the
current full year run outcomes
30/06/2013 - in € billion 31/12/2012 - in € billion
21
SOLVENCY II FRAMEWORK IS EVOLVING
22
• Parameter changes give mere indication of outcomes of 2012 impact studies
• Based on the outcomes of the long-term guarantee assessment (LTGA) proposals have been
drafted for the handling of long term guarantees in 2013, which supports finalising the Omnibus II
directive in December
• Due to the delayed introduction of Solvency II, the Dutch government decided to implement
additional regulation for Life insurers per 1 January 2014. The Theoretic Solvency Criterion (TSC)
requires Dutch Life insures to test the effect of Solvency II shocks on the Solvency I balance sheet
(‘Solvency 1.5’). This could have an impact on dividend payouts, if available capital is below TSC.
Full-year run 2012
Assumptions
Full-year run 2013
Assumptions based on
most recent proposals
Adjustment discount rate for credit risk 35 bps 10 bps
Discount rate: last liquid point 30 years 20 years
Convergence period to UFR 40 years 40 years
Countercyclical premium (CCP) 50 bps -
Volatility adjustment - 50 bps
Equity dampener +5% T.b.d.
22
Key investment considerations | Robust capital and solvency position
22
STABLE CREDIT RATING D
ec-
07
Jun
-08
De
c-08
Jun
-09
De
c-09
Jun
-10
De
c-10
Jun
-11
De
c-11
Jun
-12
De
c-12
Jun
-13
AEGON NL
Delta Lloyd
ING Insurance*
Achmea
AA
AA-
A
A-
BBB+
A+
BBB
BBB-
“The ratings predominantly reflect
our view of the group's strong
business risk profile and very
strong financial risk profile,
based on its leading Dutch
insurance franchise and very strong
capital and earnings.
The Achmea group has a strong
competitive position, in our view,
stemming from its leadership within
the Dutch insurance market.
In our opinion the group has very
strong capital and earnings.”
S&P credit rating report May 27, 2013
• Achmea was the only Dutch insurer not to be
downgraded during the crisis
• Current Group S&P rating is A- with a stable
outlook, the rating for our insurance entities is A+
also with a stable outlook.
Credit rating insurance entities
Key investment considerations | Robust capital and solvency position
23
* Counterparty credit rating / ING-V core subsidiaries rated A+
CONTENTS
Introduction
Well positioned with strong brands
Dominant player in major insurance market
Robust capital and solvency position
Key investment considerations
Recent results
Wrap-up
Conservative investment profile
Appendices
24 24
CONSERVATIVE INVESTMENT PORTFOLIO
25
• Total government bond* exposure
€ 19.5 billion, which is 58% of our fixed-income
portfolio
• Shift of € 2,8 billion (since 2012) from Dutch, German
and French government bonds to investment-grade
corporate bonds
• Exposure to GIIPS countries € 615 million (1.8% of
fixed-income portfolio)
* Including government related and government guaranteed bonds
80%
7%5%
3%2%
3%Fixed-income
Deposits
Derivatives
Equities
Alternatives
Real estate
Government*
Loans and mortgages
Asset-backed bonds
Covered bonds
Corporate bonds
Convertible bonds
Fixed-income funds
58%
9%
2%6%
23%
1%
1%
Total investment portfolio
Fixed-income by type 30/06/2013 - Total: € 33.8 billion
30/06/2013 - Total: € 42.6 billion
Key investment considerations | Conservative investment profile
25
41%
16%
22%
14%
6%1%
ACHMEA HAS A HIGH QUALITY (AA/AAA) INVESTMENT PORTFOLIO
Source: Achmea, Insurance Collateral Survey, BNY Mellon/Insurance Risk/Ernst & Young, December 2012
Achmea International peers
32%
27%8%
7%
6%
5%
5%
10%
• Compared with international peers Achmea invests more in fixed-income and less in real-estate. Achmea invests
more than half of the portfolio in government bonds with a very high quality (AA or AAA)
• Achmea has shifted to more conservative credits or corporate bonds with high seniority and short maturities
compared to ‘opportunistic’ credit of competitors
30/06/2013 31/12/2012
Key investment considerations | Conservative investment profile
Fixed-income
by rating
26
31/12/2012 30/06/2013
Investments
by type
SOVEREIGN GOVERNMENT EXPOSURE
Government bonds
Specification of GIIPS exposure
Country € mln
Greece* 10
Ireland* 524
Italy 31
Portugal 24
Spain 26
Top 5 sovereign exposure
Country € mln
The Netherlands 10,169
Germany 3,544
France 1,525
European Gov. Institutions 868
Ireland* 524
• Total governments bonds (including government
related and government guaranteed bonds)
amounts to € 19.5 billion
• Predominantly Dutch and German. Due to low
interest rates on these bonds, part is shifted to
conservative credits
• Very low exposure to GIIPS countries
* Our exposure to Greece and Ireland relates exclusively to our business activities there
30/06/2013 - Total: € 19.5 billion
Key investment considerations | Conservative investment profile
27
CONTENTS
Introduction
Group
Key investment considerations
Recent results
Wrap-up
Segments
Appendices
28
KEY MILESTONE IN RECENT YEARS – focus: optimization and innovation
• Merger with De Friesland Zorgverzekeraar, acquisition of Independer and the sale of
Achmea Vitale
• Commercial position strengthened through acquisition of niche player Friesland Bank
Assurantiën and Onderlinge Verzekeringen Overheid
• Sale of Avéro Belgium, Império France, Eureko Romania and Interamerican Bulgaria
• Agis and Achmea Health integrated
• Closed life book managed in separate organizational entity
• Investments in strengthening commercial capabilities and cooperation with
Independer.nl
• Increasing scale through consolidation (of De Friesland Zorgverzekeraar)
• Cost reduction by improved efficiencies and streamlining the organization
• Maintained Standard & Poor’s A+ rating with a stable outlook for our insurance entities
• Group capital structure further strengthened with issue of €500 million subordinated
notes, successful cash tender offer for €133 million 5.125 percent capital securities
and early redemption of €225 million 8.375 percent capital securities in first half of
2013
• Funding of Achmea Bank supported by placement of €1.3 billion of securities,
including set up of new unsecured debt issuance programme
• June 2013 Solvency (IGD) stable at 204%
• Successful placement of Mortgage Securitisation (DMPL XI) at the end of July 2013
Active portfolio
management
Operational
improvements
Strong financial
position
maintained
Recent results | Group
29
2009 - 2012: KEY PERFORMANCE TRENDS
Recent results | Group
Profit Gross written premiums
Gross operating expenses Solvency ratio (IGD)
30
H1 2013: ACHMEA POSTS NET PROFIT OF €123 MILLION
31
KEY FIGURES (IN € MLN) H1 2013 H1 2012
Net profit 123 210
Profit before tax 79 169
Gross written premiums* 17,615 18,138
Gross operating
expenses 1,347 1,346
KEY FIGURES (IN € MLN) 30/06/2013 31/12/2012
Total equity 9,763 10,483
Solvency
insurance entities (IGD) 204% 212%
S&P rating
insurance entities A+ (stable) A+ (stable)
• Result realised in challenging economic and
insurance market conditions
• All insurance segments contributed
to profit
• Gross written premiums down 3%, mainly in Health
Netherlands and Pension & Life Netherlands
• Gross operating expenses
stable despite increased pension charges,
investments in compliance with new regulations
and ongoing complexity reduction
• Robust capital position maintained, solid solvency
(IGD) of 204%
* Comparative figures H1 2012 adjusted according to changes in presentation of gross written premiums Health
Recent results | Group
31
Profit before tax
From € 82 million to
€ 177 million
Gross written premiums
From € 2,014 million to
€ 2,026 million
32
• Solid performance with a combined ratio of 97.0%
• Property & Casualty performed well, despite three major fire claims (€ 44 million)
• Various actions taken in Income Protection (WGA) resulted in improved claims ratio
NON-LIFE NETHERLANDS
Property & Casualty Income Protection
Cla
ims
ra
tio
E
xp
en
se
ra
tio
Recent results | Segments
32
93.1% 90.2% 132.0% 111.5%
Gross written premiums
From € 13,607 million to
€ 13,249 million
33
• Stable operational performance, lower profit contribution to the Group
• Healthcare premiums for customers kept stable despite rising healthcare costs
• Customers consciously selecting higher ‘own risk’ levels (Basic Health) and reducing supplementary health coverage
HEALTH NETHERLANDS
Profit before tax
From € 197 million to
€ 152 million
Basic Health Supplementary Health
Of which Basic Health
From € 135 million to
€ 118 million
Recent results | Segments
33
Cla
ims
ra
tio
E
xp
en
se
ra
tio
98.8% 97.6% 92.2% 95.4%
34
• Profitability decreased, primarily due to fair value changes related to guarantees and lower investment income
• Gross operating expenses decreased due to continued focus on cost reductions
• Rapidly changing market with customers increasingly opting for bank savings products in preference to life insurance for
asset accumulation and transition in pension products
• Separated closed life book organization further streamlined
PENSION & LIFE NETHERLANDS
Profit before tax
From € 138 million to
€ 62 million
Value of New Business (VNB)
From € -7 million to
€ -10 million
New business (APE)
From € 42 million to
€ 40 million
Recent results | Segments
34
• Banking profit of € 1 million impacted by one-off expenses
• Strong Tier 1 ratios at Achmea Bank (14.8%) and Staalbankiers (15.9%)
• Achmea Hypotheekbank successfully issued € 800 million Senior Unsecured
Notes and € 781 million of Mortgage Securitisation (DMPL XI)
INTERNATIONAL AND NON-INSURANCE ACTIVITIES
35
• Focus on improving operational performance and cost savings resulted in
profit of € 3 million
• In Turkey, Eureko Sigorta underwrote biggest insurance contract ever for
motorway project
• In Greece, continuing success of Anytime contributed significantly to growth
of market share
• Assets under Management at Syntrus Achmea increased further to € 67
billion (year-end 2012: € 64 billion)
International
Banking Netherlands
Other
Recent results | Segments
35
CONTENTS
Introduction
Investment highlights
Recent results
Wrap-up
Appendices
Summary investment highlights
36
SUMMARY INVESTMENT HIGHLIGHTS
Well positioned with strong brands
Dominant player in major insurance market
Robust capital and solvency position
Conservative investment profile
• High quality of capital and low leverage
• Strong and stable Solvency I position of 204% (IGD)
• Strong and stable credit rating (during the crisis)
• Largest Dutch insurer: high market shares in all segments
• The Netherlands is a core European country and a major insurance market
• Majority (80%) is invested in fixed-income, of which 77% is rated AA or higher
• Low asset risk compared to peers
• Strong brands, high customer satisfaction
• Well diversified distribution network
Wrap-up | Summary investment highlights
37
CONTENTS
Introduction
Key investment considerations
Recent results
Wrap-up
Appendices
38
GOOD ACCES TO CAPITAL MARKETS
39
Achmea outstanding securities
Key investment considerations | Robust capital and solvency position
39
Issuer Date issued Type Coupon (%) Coupon Type Maturity Currency Amt outst. (mln)
Achmea BV 24/06/2005 Subordinated 5.125 FLOATING Perp NC Jun 15 EUR 367
Achmea BV 01/11/2006 Subordinated 6.000 FIXED Perp NC Nov 14 EUR 600
Achmea BV 16/06/2009 Senior 7.375 FIXED 16/06/2014 EUR 750
Achmea BV 19/06/2013 Senior 1.500 FIXED 19/06/2019 CHF 200
Achmea BV 04/04/2013 Subordinated 6.000 FLOATING 04/04/2043 EUR 500
Achmea Mortgage Bank 26/02/2007 Covered 4.250 FIXED 26/02/2014 EUR 1500
Achmea Mortgage Bank 22/08/2007 Covered 3.500 FIXED 22/08/2017 CHF 200
Achmea Mortgage Bank 03/11/2009 GGB 3.200 FIXED 03/11/2014 USD 950
Achmea Mortgage Bank 03/11/2009 GGB 0.623 FLOATING 03/11/2014 USD 500
Achmea Mortgage Bank 08/11/2012 Senior 2.375 FIXED 08/02/2016 EUR 500
Achmea Mortgage Bank 23/01/2013 Senior 0.858 FLOATING 23/01/2015 EUR 300
Achmea Mortgage Bank 23/01/2013 Senior 2.000 FIXED 23/01/2018 EUR 500
REAL ESTATE EXPOSURE
40
Type € mln %
Residential 397 36
Offices 339 31
Retail 315 28
Other 60 5
Total 1,111 100
Specification of direct real estate
Real estate portfolio
• Total real estate portfolio amounts to € 1.4 billion, of
which € 0.3 billion in indirect real estate
• Well-diversified portfolio with stakes in residential,
office, retail and other real estate assets
• With the Dutch real estate market, and in particular
the office market, under sustained pressure, we
perform frequent valuations to give us a clear view
of the value of our portfolio in these turbulent market
conditions.
30/06/2013 - Total: € 1.4 billion
Appendices | Real estate exposure
40
30/06/2013 - Total: € 1.1 billion
41
Key investment considerations | Robust capital and solvency position
SENSITIVITIES
41
Date Available capital Effect interest rate
shock -1%
Effect interest rate
shock -0.4%
Effect interest rate
shock 0.4%
Effect interest rate
shock 1%
31-12-2012
9,046 58 26 -25 -48
31-12-2011
8,437 -125 -41 33 76
Asset class Effect -10% change of
market value on total equity
Effect -10% change of
market value on solvency
Equities -2% -4%
Real estate
-1% -3%
Interest rate shocks
Equity and property risk
In € million
In € million – 31-12-2012
123
DEVELOPMENT OF EQUITY H1 2013
Net profit Total equity 31/12/2012
10,483
Total equity 30/06/2013
9,763
Post-employment benefits
-49
FX reserves
-45
Revaluation of equity and fixed-income portfolio
-154
Redemption and repurchase of
equity instruments
-358
Dividends and coupons to
holders of equity instruments
-237
Appendices | Development of equity H1 2013
42
123
DEVELOPMENTS CURVES
43
Full Year Run
ECB AAA incl UFR
Achmea curve (Swap+UFR+25bp)
Swap excl UFR
Inte
rest
rat
e p
erc
en
tage
Duration
43
Appendices | Development curves
31-12-2012
43
44
Investments
by type
Source: BNP Paribas Insurance Review H1 2013
Fixed-income
by type
CONSERVATIVE INVESTMENT PROFILE COMPARED TO PEERS
45
CONTACT DETAILS
Gül Poslu Manager Investor Relations +31 (0)6 20971758 [email protected]
Bastiaan Postma Manager Investor Relations
+31 (0)6 13117581 [email protected]
Email: [email protected]
Internet: www.achmea.com
For further information, please contact Achmea Investor Relations
45
The information and the opinions in this presentation have been prepared by Achmea B.V. (the "Company" or “Achmea") solely for use at a meeting regarding a proposed offering (the "Offering") of Notes of the Company (the "Notes"). This presentation and its contents are strictly confidential, are intended only for use by the recipient for information purposes only and may not be reproduced in any form or further distributed to any other person or published, in whole or in part, for any purpose. Failure to comply with this restriction may constitute a violation of applicable securities laws. By attending the meeting where this presentation is made, or by reading the presentation slides, you agree to be bound by the following limitations.
This presentation does not constitute or form part of, and should not be construed as, an offer to sell, or the solicitation or invitation of any offer to buy or subscribe for, Notes in any jurisdiction or an inducement to enter into investment activity in any jurisdiction. No part of this presentation, nor the fact of its distribution, should form the basis of, or be relied on in connection with, any contract or commitment or investment decision whatsoever. Any purchase of the Notes in the Offering should be made solely on the basis of the Base Prospectus and Final Terms to be prepared in connection with the Offering. This presentation is the sole responsibility of the Company and has not been approved by any regulatory authority.
The information contained in this presentation has not been independently verified. No representation, warranty or undertaking, expressed or implied, is or will be made by the Company, Barclays, Citibank, HSBC, Rabobank and Unicredit or any other investment bank involved with the Offering or their respective affiliates, advisors or representatives or any other person as to, and no reliance should be placed on, the truth, fairness, accuracy, completeness or correctness of the information or the opinions contained herein (and whether any information has been omitted from the presentation). Each of Barclays, Citibank, HSBC, Rabobank and Unicredit and any other investment bank involved with the Offering and, to the extent permitted by law, the Company and each of their respective directors, officers, employees, affiliates, advisors and representatives disclaims all liability whatsoever (in negligence or otherwise) for any loss however arising, directly or indirectly, from any use of this presentation or its contents or otherwise arising in connection with this presentation.
To the extent available, the industry, market and competitive position data contained in this presentation come from official or third party sources. Third party industry publications, studies and surveys generally state that the data contained therein have been obtained from sources believed to be reliable, but that there is no guarantee of the accuracy or completeness of such data. Accordingly, undue reliance should not be placed on any of the industry, market or competitive position data contained in this presentation.
This presentation and any materials distributed in connection with this presentation are not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction.
The Notes have not been and will not be registered under the U.S. Securities Act of 1933 (the "Securities Act"), or under the securities laws of any state or other jurisdiction of the United States, and may not be offered or sold within the United States, or to, or for the account or benefit of, U.S. persons as defined in Regulation S under the Securities Act, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. Achmea does not intend to register any portion of the Offering in the United States or conduct a public offering of securities in the United States.
The distribution of this presentation and other information in connection with the Offering in certain jurisdictions may be restricted by law and persons into whose possession this presentation or any document or other information referred to herein comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.
This presentation and any materials distributed in connection with this presentation include "forward-looking statements". These statements contain the words "anticipate", “will”, "believe", "intend", "estimate", "expect" and words of similar meaning. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding the Company’s financial position, prospects, growth, business strategy, plans and objectives of management for future operations (including statements relating to, among others, expected market growth, future market share, relations with the Company's shareholders, the impact of regulatory and other related developments, demographic changes, political and economic developments, competition, branch and/or sales network growth, funding plans, interest rates, net interest margin and other financial measures, product development, information technology and potential restructurings and reorganisations) are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors, including, without limitation, the risks and uncertainties to be set forth in the Prospectus, that could cause the actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this presentation. The Company cautions you that forward-looking statements are not guarantees of future performance and that its actual financial position, prospects, growth, business strategy, plans and objectives of management for future operations may differ materially from those made in or suggested by the forward-looking statements contained in this presentation. In addition, even if the Company's financial position, prospects, growth, business strategy, plans and objectives of management for future operations are consistent with the forward-looking statements contained in this presentation, those results or developments may not be indicative of results or developments in future periods. The Company does not undertake and expressly disclaims any obligation to review or confirm or to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any events that occur or conditions or circumstances that arise after the date of this presentation. The information and opinions contained in this presentation are provided as at the date of this presentation and are subject to change without notice.
This presentation is made to and is directed only at persons who (i) if in the European Economic Area, are persons who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC) (“Qualified Investors”); and (ii) if in the United Kingdom, are (a) persons who have professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Financial Promotion Order”) or (b) high net worth entities as defined in the Financial Promotion Order or (iii) other persons to whom it may otherwise lawfully be communicated falling within Article 49(2)(a) to (e) of the Financial Promotion Order or Article 43 of the Financial Promotion Order (all such persons in (i), (ii) and (ii) above together being referred to as “relevant persons”). Any person who is not a relevant person should not act or rely on this presentation or any of its contents. Any investment or investment activity to which this presentation relates is available only to and will only be engaged in with such persons.
Each of Barclays, Citibank, HSBC, Rabobank and Unicredit, and their respective affiliates are acting for the Company and no one else in connection with the matters referred to in this presentation and will not regard any other person as their respective clients in relation to such matters and will not be responsible to any other person for providing the protections afforded to their respective clients, or for providing advice in relation to such matters.
DISCLAIMER
Disclaimer
46